© 2021 MJH Life Sciences™ and Oncology Nursing News. All rights reserved.
Dr. Sara M. Tolaney on Neoadjuvant Treatment Considerations for TNBC
July 28, 2015
Sara M. Tolaney, MD, MPH
Sara M. Tolaney, MD, MPH
Sara M. Tolaney, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer (TNBC).
Sara M. Tolaney, MD, MPH, medical oncologist, Dana-Farber Cancer Institute, discusses neoadjuvant treatment considerations for patients with triple-negative breast cancer (TNBC).
Related Content: